Enovis to Acquire LimaCorporate S.p.A.
September 25, 2023 06:00 ET
|
Enovis Corporation
Creating a high-growth, global reconstruction leader with ~$1 billion in annual revenueAttractive margin profile and meaningful synergies expected to increase profitability Wilmington, DE,...
Enovis Debuts New Foot & Ankle Offerings at the AOFAS Annual Meeting
September 18, 2023 08:30 ET
|
Enovis Corporation
Wilmington, DE, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, announced it will showcase new products from its recent...
Enovis to Participate in Upcoming Investor Conferences
August 08, 2023 08:24 ET
|
Enovis Corporation
Wilmington, DE, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate...
Enovis Announces Second Quarter 2023 Results and Raises Full-Year Outlook
August 03, 2023 06:00 ET
|
Enovis Corporation
Continued strong momentum with second quarter sales growth of 8% and strong EBITDA margin expansionOrganic growth of 17% in Recon and 4% in P&R Reported a second quarter net loss from...
Enovis to Host Second Quarter 2023 Results Conference Call on August 3rd
July 11, 2023 16:45 ET
|
Enovis Corporation
Wilmington, DE, July 11, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will host an investor conference...
Enovis™ Recognized as One of America’s Greatest Workplaces 2023 by Newsweek
July 06, 2023 08:30 ET
|
Enovis Corporation
Wilmington, DE, July 06, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced today that it has been recognized as one of...
Enovis™ Completes Acquisition of Novastep®
June 28, 2023 16:30 ET
|
Enovis Corporation
Wilmington, DE, June 28, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it closed the acquisition of...
Enovis to Participate in Investor Conferences in June
June 02, 2023 16:01 ET
|
Enovis Corporation
Wilmington, DE, June 02, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will...
Enovis Announces First Quarter 2023 Results
May 04, 2023 06:00 ET
|
Enovis Corporation
Strong start to the year with sales growth of 8%, organic growth of 9% and strong EBITDA margin expansionOrganic growth of 9% reflects 19% organic growth in Recon and 4% organic growth in...
Enovis to Host First Quarter 2023 Results Conference Call on May 4th
April 13, 2023 12:21 ET
|
Enovis Corporation
Wilmington, DE, April 13, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...